ResearchDx, a contract diagnostics organization (CDO), has announced its purchase of and relocation to a 30,000-square-foot facility in Irvine, Calif. The facility will support continued expansion of in vitro diagnostic (IVD) development services to the pharmaceutical, biotechnology, diagnostic development and clinical laboratory industries.

According to ResearchDx, new healthcare initiatives toward personalized medicine and the corresponding need for IVD tests to come to market alongside pharmaceuticals as companion diagnostics (CDx) is changing the way drug companies target diseases and treatments for patients.